Jason Hosken
@jasonhosken
I make @TheEconomist's science and tech podcast, Babbage
ID: 314434900
10-06-2011 07:46:03
151 Tweet
268 Followers
388 Following
Protecting #women from online abuse - 4 #BigTech companies commit to help - azzy/elle! from World Wide Web Foundation and Arzu Geybulla. Pacemakers that dissolve in the body Northwestern + tech to capture microplastics from car tyres Sig. Ottavio Lucarelli Jason Hosken bbc.co.uk/programmes/w3c…
Microplastics are everywhere. Can tech help? My latest for BBC Digital Planet on BBC World Service. With Healthy Earth NGO and Sig. Ottavio Lucarelli
Very proud to have been shortlisted with Natasha Loder 🦋🐝 The Economist Congrats to the excellent winners
A joy to make this episode with Shashank Joshi 🕵️♂️
Thanks to Alison Woollard for being a star biology teacher!
“It really attacks us throughout various stages of our lives.” @audreydenazelle, environmental-policy expert at Imperial College London, explains the impact that air pollution has on human health. Listen to “Babbage” econ.trib.al/rVe70hS
On “Babbage”, with Kenneth Cukier: - Will web3 reinvent the internet business? - What is the technology behind the idea? - Is decentralising the web really desirable? econ.st/3rDNoTg
So incredibly bleak. Hard to find the right words. Audio journalism at its best from Kim Gittleson and William Warren
The idea for the piece emerged from conversations with a lot of fascinating, passionate scientists who were very generous with their time. I'm particularly grateful to Raquel Peixoto and Keri O'Neil The Florida Aquarium for also coming on our Babbage podcast economist.com/podcasts/2022/… (3/5)
This was an amazing story to work on with Jason Hosken. Ketamine can be transformative for some patients with depression. But there are risks and concerns as the off label use of generic ketamine becomes more popular.
Spoiler alert: it’s not the vaccine. Most of them never even had the vaccine. They’re too young. Listen for brilliant detective work from Kenneth Cukier 🕵️♂️
It was such a pleasure to work with Jason Hosken to make this podcast show happen and showcase incredible #T1Dresearch on such a huge platform. Listen to the latest episode of The Economist’s science podcast to learn how we are surging towards a cure for #Type1Diabetes.
Here’s ten of our favourite episodes from 2022, with Alok Jha Kenneth Cukier Hannah Marinho @NicoRaufast
I enjoyed my conversation with Ugur Sahin of BioNTech SE about what lies ahead this year for mRNA medicines. I hope you will too.